{"id":93510,"topic":"peptides","source":"新浪财经","title":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流 - 新浪财经","url":"https://wap.cj.sina.cn/7x24/5120845","url_hash":"563729ad263c514018badd824cad4d7816d279a2","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMiS0FVX3lxTE9RcnBHYi1fUEkwRkpsbkcyQlU4R21BSmlWdHN5Y200aUJqLTJ4VzZUUXFCbFNMd29rdDZ0T2tqWDZWMl91TGViWE9vVQ?oc=5\" target=\"_blank\">九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">新浪财经</font>","content":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流\n            \n            \n                九典制药公告称，公司拟终止“抗菌多肽新药研发项目”，将该项目剩余募集资金9849.18万元永久补充流动资金，用于主营业务相关日常经营活动，本次补流金额占2021年可转债募资总额的36.48%。截至2026年6月30日，该项目累计投入募集资金301.56万元，投入进度3.07%。该事项已经公司董事会审议通过，尚需提交股东会审议。\n            \n            \n            声明：以上内容仅供资讯传播，不构成与新浪财经相关的任何投资建议。","image_url":null,"lang":"zh","published_at":"2026-09-30T10:11:34+00:00","fetched_at":"2026-09-30T11:15:13+00:00","status":"read","starred":0,"extract_state":"ok","summary_auto":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流\n            \n            \n               …","cluster_id":3495435,"extract_retries":0,"extract_error":null,"contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://wap.cj.sina.cn/7x24/5120845","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 303 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":303,"summary_length":68,"usable_text_length":303,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":303,"summary_length":68}},"news_item":{"id":93510,"canonical_url":"https://wap.cj.sina.cn/7x24/5120845","source_url":"https://wap.cj.sina.cn/7x24/5120845","title":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流 - 新浪财经","source_name":"新浪财经","author":null,"published_at":"2026-09-30T10:11:34+00:00","locale":"zh","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMiS0FVX3lxTE9RcnBHYi1fUEkwRkpsbkcyQlU4R21BSmlWdHN5Y200aUJqLTJ4VzZUUXFCbFNMd29rdDZ0T2tqWDZWMl91TGViWE9vVQ?oc=5\" target=\"_blank\">九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">新浪财经</font>","full_text":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流\n            \n            \n                九典制药公告称，公司拟终止“抗菌多肽新药研发项目”，将该项目剩余募集资金9849.18万元永久补充流动资金，用于主营业务相关日常经营活动，本次补流金额占2021年可转债募资总额的36.48%。截至2026年6月30日，该项目累计投入募集资金301.56万元，投入进度3.07%。该事项已经公司董事会审议通过，尚需提交股东会审议。\n            \n            \n            声明：以上内容仅供资讯传播，不构成与新浪财经相关的任何投资建议。","excerpt":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流\n            \n            \n               …","extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 303 characters.","diagnostics_url":"/api/diagnose?url=https%3A//wap.cj.sina.cn/7x24/5120845","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 303 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":303,"summary_length":68,"usable_text_length":303,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":303,"summary_length":68}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流 - 新浪财经","url":"https://wap.cj.sina.cn/7x24/5120845","summary":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流\n            \n            \n               …","source":"新浪财经","date":"2026-09-30T10:11:34+00:00","content":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流\n            \n            \n                九典制药公告称，公司拟终止“抗菌多肽新药研发项目”，将该项目剩余募集资金9849.18万元永久补充流动资金，用于主营业务相关日常经营活动，本次补流金额占2021年可转债募资总额的36.48%。截至2026年6月30日，该项目累计投入募集资金301.56万元，投入进度3.07%。该事项已经公司董事会审议通过，尚需提交股东会审议。\n            \n            \n            声明：以上内容仅供资讯传播，不构成与新浪财经相关的任何投资建议。","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//wap.cj.sina.cn/7x24/5120845","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 303 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 303 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":303,"summary_length":68,"usable_text_length":303,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":303,"summary_length":68}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/93510","export_markdown":"/api/items/93510/export?format=markdown","export_json":"/api/items/93510/export?format=json","diagnose":"/api/diagnose?url=https%3A//wap.cj.sina.cn/7x24/5120845"},"formats":{"full":{"id":93510,"title":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流 - 新浪财经","url":"https://wap.cj.sina.cn/7x24/5120845","source":"新浪财经","author":null,"published_at":"2026-09-30T10:11:34+00:00","locale":"zh","topic":"peptides","tags":[],"excerpt":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流\n            \n            \n               …","full_text":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流\n            \n            \n                九典制药公告称，公司拟终止“抗菌多肽新药研发项目”，将该项目剩余募集资金9849.18万元永久补充流动资金，用于主营业务相关日常经营活动，本次补流金额占2021年可转债募资总额的36.48%。截至2026年6月30日，该项目累计投入募集资金301.56万元，投入进度3.07%。该事项已经公司董事会审议通过，尚需提交股东会审议。\n            \n            \n            声明：以上内容仅供资讯传播，不构成与新浪财经相关的任何投资建议。","reading_time_min":1,"extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 303 characters.","diagnostics_url":"/api/diagnose?url=https%3A//wap.cj.sina.cn/7x24/5120845","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 303 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":303,"summary_length":68,"usable_text_length":303,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":303,"summary_length":68}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 303 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":303,"summary_length":68,"usable_text_length":303,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":303,"summary_length":68}},"actions":{"read":"/item/93510","export_markdown":"/api/items/93510/export?format=markdown","export_json":"/api/items/93510/export?format=json","diagnose":"/api/diagnose?url=https%3A//wap.cj.sina.cn/7x24/5120845"}},"digest":{"id":93510,"title":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流 - 新浪财经","url":"https://wap.cj.sina.cn/7x24/5120845","source":"新浪财经","topic":"peptides","published_at":"2026-09-30T10:11:34+00:00","excerpt":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流 …","quality_bucket":"high","quality_reason":"High confidence: full text extraction produced 303 characters.","reading_time_min":1,"cluster_id":3495435},"card":{"display_title":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流 - 新浪财经","subtitle":"新浪财经 · 2026-09-30","summary":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流 …","badges":["quality:high"],"links":{"read":"/item/93510","original":"https://wap.cj.sina.cn/7x24/5120845","diagnose":"/api/diagnose?url=https%3A//wap.cj.sina.cn/7x24/5120845"},"quality_warning":null},"export":{"title":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流 - 新浪财经","url":"https://wap.cj.sina.cn/7x24/5120845","summary":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流\n            \n            \n               …","source":"新浪财经","date":"2026-09-30T10:11:34+00:00","content":"九典制药：拟终止抗菌多肽新药研发项目 剩余募资补流\n            \n            \n                九典制药公告称，公司拟终止“抗菌多肽新药研发项目”，将该项目剩余募集资金9849.18万元永久补充流动资金，用于主营业务相关日常经营活动，本次补流金额占2021年可转债募资总额的36.48%。截至2026年6月30日，该项目累计投入募集资金301.56万元，投入进度3.07%。该事项已经公司董事会审议通过，尚需提交股东会审议。\n            \n            \n            声明：以上内容仅供资讯传播，不构成与新浪财经相关的任何投资建议。","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//wap.cj.sina.cn/7x24/5120845","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 303 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 303 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":303,"summary_length":68,"usable_text_length":303,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":303,"summary_length":68}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}